Eden vs Found
Eden has an open FDA warning letter dated June 8, 2026. Found has none. On compounded tirzepatide injection, Eden costs $3,119 less a year at standing rates: $129 a month against $359 a month (billed every 4 weeks) at Found. It is one of two products the two sell at comparable terms.
The record
Eden / Found
Eden
8.7/10
Found
7.3/10
Both Eden and Found are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Eden 8.7, Found 7.3). How we are paid
What the record shows
- 01
Eden has an open FDA warning letter dated June 8, 2026. Found has none.
- 02
Neither names the pharmacy that compounds its medication.
- 03
On compounded tirzepatide injection, Eden costs $3,119 less a year at standing rates: $129 a month against $359 a month (billed every 4 weeks) at Found. It is one of two products the two sell at comparable terms.
- 04
Only Found lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and Foundayo (orforglipron) pill.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Eden
Found
$99/moLower
$1,188 a year
$289/mo
$3,757 a year, 13 charges
$129/moLower
$1,548 a year
$359/mo
$4,667 a year, 13 charges
$199/mo
medication only, membership extra; not compared
$299/mo
medication only, membership extra; not compared
$149/mo
medication only, membership extra; not compared
Read off each seller’s own pages. Eden: October 25, 2026. Found: October 17, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Eden
8.7/10- $2,569 a year less on compounded semaglutide injection
- $3,119 a year less on compounded tirzepatide injection
- Open FDA warning letter, June 8, 2026
- Names no compounding pharmacy
The case for Found
7.3/10- No FDA warning letter on record
- Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Eden does not price
- Names no compounding pharmacy
Scores
Eden 8.7 · Found 7.3 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Eden vs Found: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- SnagRx8.6
From $99/mo
Visit site - MEDGm6.6
From $169/mo prepaid
Visit site - HumeCare+6.6
From $199/mo
Visit site
Sellers closest to these two
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks